DOI QR코드

DOI QR Code

The role of bladder sonography in patients with gross hematuria or microscopic hematuria and follow-up of patients with superficial bladder cancer

방광종물에 대한 방광초음파검사의 진단적 유용성

  • Huh, Jung-Sik (Department of Urology, Jeju National University Hospital, Jeju National University, Graduate School of Medicine) ;
  • Kim, Sung Dae (Department of Urology, Jeju National University Hospital, Jeju National University, Graduate School of Medicine) ;
  • Park, Kyung Kgi (Department of Urology, Jeju National University Hospital, Jeju National University, Graduate School of Medicine) ;
  • Kim, Young Joo (Department of Urology, Jeju National University Hospital, Jeju National University, Graduate School of Medicine) ;
  • You, Hyun Wook (Happy Urologic Clinics)
  • 허정식 (제주대학교 의학전문대학원 비뇨기과학교실) ;
  • 김성대 (제주대학교 의학전문대학원 비뇨기과학교실) ;
  • 박경기 (제주대학교 의학전문대학원 비뇨기과학교실) ;
  • 김영주 (제주대학교 의학전문대학원 비뇨기과학교실) ;
  • 유현욱 (유쾌한비뇨기과의원)
  • Received : 2020.10.20
  • Accepted : 2020.12.08
  • Published : 2020.12.31

Abstract

Ultrasonography is used to examine gross or microscopic hematuria without side effects. It is one of the methods of diagnosing bladder lesions, but in some cases, the lesions are not found. We attempted to identify the problems during the ultrasonic examination by analyzing the symptoms, location of lesion, and medical history of urothelial cancer for cases of undetected bladder lesions. Thirty-three patients who underwent transurethral resection of a bladder tumor from January 1 to May 4, 2018 in one hospital were enrolled in this study. Patients who underwent preoperative ultrasonography and cystoscopy were treated. Ultrasonography did not detect bladder lesions in five patients. The size of the lesion was 0.5~2.5 cm in various locations, such as the side, front, and so on. Ultrasonic examination requires more attention if there is gross hematuria or a history of urothelial cancer, and it is necessary to detect recurrence by conducting cystoscopy at the same time, especially when there are lesions on the anterior wall of the bladder.

Keywords

References

  1. Park KK, Kim SD, Kim YJ, Huh JS. Trends in urogenital cancer incidence in Jeju (1999-2012). Korean J Urol Oncol 2016;14:27-31.
  2. D'Elia C, Pycha A, Folchini DM, Mian C, Hanspeter E, Schwienbacher C, et al. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer. J Clin Pathol 2019;72:140-4. https://doi.org/10.1136/jclinpath-2018-205393
  3. Hori S, Miyake M, Tatsumi Y, Morizawa Y, Nakai Y, Onishi S, et al. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette-Guerin by the modulation of the tumor immune environment. Oncol Rep 2019;41:1863-74.
  4. Usuba W, Urabe F, Yamamoto Y, Matsuzaki J, Sasaki H, Ichikawa M, et al. Circulating miRNA panels for specific and early detection in bladder cancer. Cancer Sci 2019;110:408-19. https://doi.org/10.1111/cas.13856